From: GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Rs2304166 genotype (N = 86) | Pre-NTZ treatment | Post 2-year NTZ treatment | ||
---|---|---|---|---|
EDSS [Median (IQRa)] | EDSS [Median (IQR)] | New CNS lesion (n) | Relapse (n) | |
GG | 3.5 (2.5–4.5) | 3 (2–4.75) | 0 | 0 |
GC | 2 (2.5–4.25) | 2 (1.5–4.25) | 0 | 0 |
CC | 3.5 (2–5.87) | 5.25 (2–6.5) | 2 | 2 |